Docusate sodium 50 mg in 5 mL Oral Suspension
RxNorm 1248119
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1248119 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: docusate sodium 50 mg in 5 mL Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Docusate sodium 10 mg/ML Oral Suspension
(Atom ID: 12345508)
SYPrescribable
Synonym (SY):
Docusate sodium 100 mg per 10 mL Oral Suspension
(Atom ID: 4255232)
SYPrescribable
Synonym (SY):
Docusate sodium 150 mg per 15 mL Oral Suspension
(Atom ID: 4255233)
PSNPrescribable
Prescribable Name (PSN):
Docusate sodium 50 mg in 5 mL Oral Suspension
(Atom ID: 8697700)
SYPrescribable
Synonym (SY):
Docusate sodium 50 mg per 5 mL Oral Suspension
(Atom ID: 4255234)
SYPrescribable
Synonym (SY):
DOSS Sodium 10 mg/ML Oral Suspension
(Atom ID: 4255336)
Patient Education
Stool Softeners
Stool softeners are used on a short-term basis to relieve constipation by people who should avoid straining during bowel movements because of heart conditions, hemorrhoids, and other problems. They work by softening stools to make them easier to pass.
[Learn More]
* Please review the disclaimer below.